On November 24, Lilly Pharmaceutical and Boehringer Ingelheim jointly announced that Outangjing& Reg; The new indication of Engliflozin has been approved by the National Drug Administration of China ...

semaglutide, the "miracle drug" for weight loss, promises to expand even further - not only to lose weight, but perhaps to treat kidney disease. On October 10, Novo Nordisk announced that the Phase 3 ...